Research and Development

With the retirement of Elias Zerhouni as Head of Global R&D, Sanofi had to find a suitable replacement and believes …

The year seems like it’s running away as we come to the end of April. It’s been a more tense …

EIi Lilly has announced plans to partner up with China’s National Center for Cardiovascular Diseases (NCCD), the nation’s institution responsible …

Alexion has lifted the curtain on new data for its C5 complement inhibitor ALXN1210, demonstrating its non-inferiority to another of …

Kristina Barrick is the Digital Innovation Manager at Breast Cancer Care and leads on the development of BECCA, the Breast …

A Cancer Research UK-funded study undertaken by the University of Glasgow has revealed that representation and coverage of cancer patients …

Researchers at St Louis Washington University School of Medicine have uncovered a promising extra application of a particular Janus Kinase …

Hans Bishop, CEO and Co-founder of Juno Therapeutics who helped set up the company in 2013 and has since grown …

There is a growing trend in big pharma to talk up the potential for digital technology to revolutionise operations and …

With the retirement of Elias Zerhouni as Head of Global R&D, Sanofi had to find a suitable replacement and believes …

From March onwards, Takeda has been nudging a deal with Shire onwards through repeatedly improved offers, which has seen the …

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced that sodium valproate, a drug used in the treatment …

AstraZeneca has been hit by a fresh blow in its search for an immunotherapy combination treatment that could differentiate it …

Just in time for the first good weather of the year, the May 2018 edition of Pharmafocus is available to …

Shares in Prothena have dropped by close to 70% on the news that two of its trials into its lead …